-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
StockNews.com Initiates Coverage on Cellectar Biosciences (NASDAQ:CLRB)
Equities researchers at StockNews.com initiated coverage on shares of Cellectar Biosciences (NASDAQ:CLRB – Get Free Report) in a report released on Sunday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. A number of other research analysts have also commented on CLRB. LADENBURG THALM/SH SH assumed coverage on Cellectar Biosciences in a report […]
Equities researchers at StockNews.com initiated coverage on shares of Cellectar Biosciences (NASDAQ:CLRB – Get Free Report) in a report released on Sunday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. A number of other research analysts have also commented on CLRB. LADENBURG THALM/SH SH assumed coverage on Cellectar Biosciences in a report […]
